ARS Pharmaceuticals, Inc (SPRY) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $9.34
• Market Cap: $913.36M
• EPS: $-0.81
• 52-Week High: $18.90
• 52-Week Low: $6.66

Market Sentiment

ARS Pharmaceuticals, Inc currently has a Neutral sentiment score of 0.12.

About ARS Pharmaceuticals, Inc

ARS Pharmaceuticals, Inc. is an innovative biopharmaceutical company based in San Diego, California, focused on developing ARS-1, an advanced intranasal epinephrine aerosol designed to provide rapid relief for individuals at risk of life-threatening allergic reactions. By leveraging proprietary absorption technology, ARS-1 aims to improve the accessibility and usability of epinephrine delivery, catering to the needs of patients and their families. The company's commitment to addressing critic...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for ARS Pharmaceuticals, Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does SPRY pay dividends?

ARS Pharmaceuticals, Inc (SPRY) does not currently pay a regular dividend.

What is SPRY's market cap?

ARS Pharmaceuticals, Inc (SPRY) has a market capitalization of $913.36M with a current stock price of $9.34.